B-cell maturation antigen, also known as tumor necrosis factor receptor superfamily member 17, is a protein that in humans is encoded by the TNFRSF17 gene. From Wikipedia
The MHRA authorizes Blenrep for relapsed or refractory multiple myeloma based on pivotal Phase 3 trial data, with reviews underway in 14 countries.
